Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Open-label Study of Trospium Delivered Intravesically by TAR-302-5018 to Subjects With Idiopathic Overactive Bladder (iOAB) and Urinary Incontinence

NCT03109379 is registered in ClinicalTrials.gov with Taris Biomedical LLC as lead sponsor.

NCT NCT03109379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03109379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Open-label Study of Trospium Delivered Intravesically by TAR-302-5018 to Subjects With Idiopathic Overactive Bladder (iOAB) and Urinary Incontinence
Lead sponsor
Taris Biomedical LLC
Phase
Phase 1
Overall status
Completed
Start date
April 4, 2017
Completion date
September 27, 2019
Enrollment
43 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic overactive bladder with urinary incontinence